Cargando…
Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma
The present retrospective study was undertaken to investigate the association of relative dose intensity (RDI) with the outcome of patients with advanced stage Hodgkin lymphoma (HL) receiving ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) and escalated BEACOPP regimens (bleomycin, etoposide...
Autores principales: | Rožman, Samo, Jezeršek Novaković, Barbara, Ružić Gorenjec, Nina, Novaković, Srdjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353858/ https://www.ncbi.nlm.nih.gov/pubmed/35949614 http://dx.doi.org/10.3892/ol.2022.13440 |
Ejemplares similares
-
The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients
por: ROŽMAN, SAMO, et al.
Publicado: (2016) -
Population pharmacokinetics of rituximab in patients with diffuse large B‐cell lymphoma and association with clinical outcome
por: Rozman, Samo, et al.
Publicado: (2017) -
Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
por: Jezeršek Novaković, Barbara, et al.
Publicado: (2021) -
Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma
por: Novakovic, Barbara Jezersek
Publicado: (2015) -
Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas
por: KOKOVIC, IRA, et al.
Publicado: (2014)